Modified Clavanin A
General Information
DRACP ID DRACP03661
Peptide Name Modified Clavanin A
Sequence FLPIIVFQFLGKIIHHVGNFVHGFSHVF
Sequence Length 28
UniProt ID P80710
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antiviral; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C163H233N39O32
Absent amino acids ACDEMRTWY
Common amino acids F
Mass 373267
Pl 9.71
Basic residues 5
Acidic residues 0
Hydrophobic residues 16
Net charge 5
Boman Index 2661
Hydrophobicity 113.93
Aliphatic Index 125
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 27804992
Title An anti-infective Synthetic peptide peptide with dual antimicrobial and immunomodulatory activities
Doi Not available
Year 2016
Literature 2
Pubmed ID 27161201
Title Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus
Doi Not available
Year 2017
Literature 3
Pubmed ID 28712894
Title Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and LL-37, in vitro: An endodontic perspective
Doi Not available
Year 2017
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 10589